TY - JOUR
T1 - Multimodal decoding of human liver regeneration
AU - Matchett, K.P.
AU - Wilson-Kanamori, J R
AU - Portman, Jordan
AU - Kapourani, CA
AU - Fercoq, Frédéric
AU - May, S.
AU - Zajdel, Ewa
AU - Beltran, M
AU - Sutherland, Elena
AU - Mackey, J B G
AU - Brice, Madara
AU - Wilson, Grace
AU - Wallace, SJ
AU - Kitto, Laura
AU - N, Younger
AU - Dobie, Ross
AU - Mole, Damian J
AU - Oniscu, Gabriel
AU - Wigmore, Stephen J
AU - Ramachandran, Prakash
AU - Vallejos, CA
AU - Carragher, Neil O
AU - saeidinejad, MM
AU - Quaglia, A
AU - Jalan, Rajiv
AU - Simpson, KJ
AU - Kendall, Timothy J.
AU - Rule, JA
AU - Lee, W
AU - Hoare, M
AU - Weston, C J
AU - Marioni, J C
AU - Teichmann, S A
AU - Bird, Thomas G
AU - Carlin, L
AU - Henderson, Neil C
PY - 2024/5/1
Y1 - 2024/5/1
N2 - The liver has a unique ability to regenerate
1,2; however, in the setting of acute liver failure (ALF), this regenerative capacity is often overwhelmed, leaving emergency liver transplantation as the only curative option
3-5. Here, to advance understanding of human liver regeneration, we use paired single-nucleus RNA sequencing combined with spatial profiling of healthy and ALF explant human livers to generate a single-cell, pan-lineage atlas of human liver regeneration. We uncover a novel ANXA2
+ migratory hepatocyte subpopulation, which emerges during human liver regeneration, and a corollary subpopulation in a mouse model of acetaminophen (APAP)-induced liver regeneration. Interrogation of necrotic wound closure and hepatocyte proliferation across multiple timepoints following APAP-induced liver injury in mice demonstrates that wound closure precedes hepatocyte proliferation. Four-dimensional intravital imaging of APAP-induced mouse liver injury identifies motile hepatocytes at the edge of the necrotic area, enabling collective migration of the hepatocyte sheet to effect wound closure. Depletion of hepatocyte ANXA2 reduces hepatocyte growth factor-induced human and mouse hepatocyte migration in vitro, and abrogates necrotic wound closure following APAP-induced mouse liver injury. Together, our work dissects unanticipated aspects of liver regeneration, demonstrating an uncoupling of wound closure and hepatocyte proliferation and uncovering a novel migratory hepatocyte subpopulation that mediates wound closure following liver injury. Therapies designed to promote rapid reconstitution of normal hepatic microarchitecture and reparation of the gut-liver barrier may advance new areas of therapeutic discovery in regenerative medicine.
AB - The liver has a unique ability to regenerate
1,2; however, in the setting of acute liver failure (ALF), this regenerative capacity is often overwhelmed, leaving emergency liver transplantation as the only curative option
3-5. Here, to advance understanding of human liver regeneration, we use paired single-nucleus RNA sequencing combined with spatial profiling of healthy and ALF explant human livers to generate a single-cell, pan-lineage atlas of human liver regeneration. We uncover a novel ANXA2
+ migratory hepatocyte subpopulation, which emerges during human liver regeneration, and a corollary subpopulation in a mouse model of acetaminophen (APAP)-induced liver regeneration. Interrogation of necrotic wound closure and hepatocyte proliferation across multiple timepoints following APAP-induced liver injury in mice demonstrates that wound closure precedes hepatocyte proliferation. Four-dimensional intravital imaging of APAP-induced mouse liver injury identifies motile hepatocytes at the edge of the necrotic area, enabling collective migration of the hepatocyte sheet to effect wound closure. Depletion of hepatocyte ANXA2 reduces hepatocyte growth factor-induced human and mouse hepatocyte migration in vitro, and abrogates necrotic wound closure following APAP-induced mouse liver injury. Together, our work dissects unanticipated aspects of liver regeneration, demonstrating an uncoupling of wound closure and hepatocyte proliferation and uncovering a novel migratory hepatocyte subpopulation that mediates wound closure following liver injury. Therapies designed to promote rapid reconstitution of normal hepatic microarchitecture and reparation of the gut-liver barrier may advance new areas of therapeutic discovery in regenerative medicine.
KW - Acetaminophen/pharmacology
KW - Animals
KW - Cell Lineage
KW - Cell Movement/drug effects
KW - Cell Proliferation/drug effects
KW - Chemical and Drug Induced Liver Injury/pathology
KW - Disease Models, Animal
KW - Female
KW - Hepatocyte Growth Factor/metabolism
KW - Hepatocytes/cytology
KW - Humans
KW - Liver Failure, Acute/pathology
KW - Liver Regeneration/drug effects
KW - Liver/cytology
KW - Male
KW - Mice
KW - Mice, Inbred C57BL
KW - Necrosis/chemically induced
KW - Regenerative Medicine
KW - Single-Cell Gene Expression Analysis
KW - Wound Healing
U2 - 10.1038/s41586-024-07376-2
DO - 10.1038/s41586-024-07376-2
M3 - Article
C2 - 38693268
SN - 0028-0836
VL - 630
SP - 158
EP - 165
JO - Nature
JF - Nature
IS - 8015
ER -